Movicol Orange (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 acts as an osmotic agent; it retains water and electrolytes within the intestinal lumen, softening stool and expanding its volume. This osmotic effect stimulates peristalsis, helping the bowel move contents more effectively toward evacuation.

The appropriate dose of Movicol Orange is determined by the prescribing healthcare professional based on the patient’s age, severity of constipation, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Movicol Orange in pregnancy or lactation has not been definitively established. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing it to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Movicol Orange (macrogol 3350) works by osmotic water retention rather than stimulating intestinal muscle activity, often resulting in a gentler, more predictable effect and a lower incidence of cramping. It is also formulated with electrolytes to help maintain fluid balance.

Movicol Orange should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and store it in its original packaging until use.

Movicol Orange is taken orally as a measured dose of the liquid solution. It is usually mixed with a specified amount of water or other clear fluid as directed by the prescriber, and the mixture is consumed promptly.

Serious risks include severe electrolyte disturbances such as hyponatraemia or hypokalaemia, acute renal impairment in susceptible patients, and rare allergic reactions like rash or angioedema. Prompt medical attention is required if any of these occur.

Movicol Orange should be avoided in individuals with known or suspected intestinal obstruction, severe renal impairment, or significant electrolyte abnormalities. Patients with hypersensitivity to any component of the formulation should also refrain from using it.